In the future, disruptive innovation in radiation oncology technology will be initiated mostly by entrepreneurs.
Publication
, Journal Article
Yu, CX; Bortfeld, T; Cai, J
Published in: Med Phys
May 2019
Duke Scholars
Published In
Med Phys
DOI
EISSN
2473-4209
Publication Date
May 2019
Volume
46
Issue
5
Start / End Page
1949 / 1952
Location
United States
Related Subject Headings
- Radiation Oncology
- Organizational Innovation
- Nuclear Medicine & Medical Imaging
- Humans
- Health Care Sector
- Entrepreneurship
- Commerce
- 5105 Medical and biological physics
- 4003 Biomedical engineering
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Yu, C. X., Bortfeld, T., & Cai, J. (2019). In the future, disruptive innovation in radiation oncology technology will be initiated mostly by entrepreneurs. Med Phys, 46(5), 1949–1952. https://doi.org/10.1002/mp.13524
Yu, Cedric X., Thomas Bortfeld, and Jing Cai. “In the future, disruptive innovation in radiation oncology technology will be initiated mostly by entrepreneurs.” Med Phys 46, no. 5 (May 2019): 1949–52. https://doi.org/10.1002/mp.13524.
Yu CX, Bortfeld T, Cai J. In the future, disruptive innovation in radiation oncology technology will be initiated mostly by entrepreneurs. Med Phys. 2019 May;46(5):1949–52.
Yu, Cedric X., et al. “In the future, disruptive innovation in radiation oncology technology will be initiated mostly by entrepreneurs.” Med Phys, vol. 46, no. 5, May 2019, pp. 1949–52. Pubmed, doi:10.1002/mp.13524.
Yu CX, Bortfeld T, Cai J. In the future, disruptive innovation in radiation oncology technology will be initiated mostly by entrepreneurs. Med Phys. 2019 May;46(5):1949–1952.
Published In
Med Phys
DOI
EISSN
2473-4209
Publication Date
May 2019
Volume
46
Issue
5
Start / End Page
1949 / 1952
Location
United States
Related Subject Headings
- Radiation Oncology
- Organizational Innovation
- Nuclear Medicine & Medical Imaging
- Humans
- Health Care Sector
- Entrepreneurship
- Commerce
- 5105 Medical and biological physics
- 4003 Biomedical engineering
- 1112 Oncology and Carcinogenesis